FDA Adverse Event Malfunction Summary report: N

TEXIUM CLOSED MALE LUER

MDR report key: 5729427 · Received June 16, 2016

Report

Report Number
9616066-2016-00804
Event Type
Malfunction
Date Received
June 16, 2016
Date of Event
May 20, 2016
Report Date
June 2, 2016
Manufacturer
CAREFUSION
Product Code
FPA
PMA / PMN Number
K053049
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WA, US
Reporter Occupation
PHARMACIST

Narratives

Additional Manufacturer Narrative · 1

THE AFFECTED PRODUCT HAS BEEN RECEIVED AND THE EVALUATION IS PENDING. A FOLLOW UP REPORT WILL BE SUBMITTED ONCE THE EVALUATION IS COMPLETED.

Additional Manufacturer Narrative · 1

THE CUSTOMER¿S REPORT THAT A SYRINGE LEAKED DURING AN IV PUSH WAS CONFIRMED. VISUAL INSPECTION SHOWED THAT THE DISTAL HUB OF THE 1ML SYRINGE WAS BROKEN OFF INTO 3 PIECES AND THE EDGES WERE JAGGED. THREE VERTICAL CRACKS WERE OBSERVED ON THE WHITE FEMALE LUER BODY (FLB) OF THE TEXIUM CONNECTOR. THE CRACKS EXTENDED ALMOST COMPLETELY FROM THE PROXIMAL FEMALE END TO THE DISTAL END OF THE FLB AND COMPLETELY FROM THE INTERIOR TO THE EXTERIOR OF THE FLB. THERE WAS NO EVIDENCE OF TOOL MARKS. FUNCTIONAL TESTING WAS NOT PERFORMED DUE TO THE DAMAGED CONDITION OF THE RECEIVED PRODUCTS. THE ROOT CAUSE WAS IDENTIFIED TO BE OVER-TORQUE EXERTED DURING USE, CAUSING THE CRACKING OF THE TEXIUM BODY AND THE SYRINGE MALE LUER HUB, RESULTING IN THE LEAK.

Description of Event or Problem · 1

THE CUSTOMER REPORTED LEAKING OF TESTOSTERONE 150MG, 0.75ML DURING AN IV PUSH. ALTHOUGH THE PATIENT DID NOT RECEIVE THE ENTIRE DOSE AND IT WAS NOT KNOWN HOW MUCH OF THE DOSE WAS ACTUALLY RECEIVED, THERE WAS NO REPORT OF PATIENT OR PROVIDER HARM.

Description of Event or Problem · 1

THE CUSTOMER REPORTED LEAKING OF AN UNSPECIFIED MEDICATION DURING AN IV PUSH. THERE WAS NO REPORT OF PATIENT OR PROVIDER HARM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
383290 TEXIUM CLOSED MALE LUER SET, ADMINISTRATION, INTRAVASCULAR FPA CAREFUSION 10012241-0500

Patients

Seq Age Sex Outcome Treatment
1 16 YR